Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Winrow

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 8, 2016
Discovery of highly potent and selective orexin 1 receptor antagonists (1-SORAs) suitable for in vivo interrogation of orexin 1 receptor pharmacologyCraig A Stump, Andrew J Cooke, Joseph Bruno, et al.
Frontiers in Behavioral Neuroscience|June 7, 2014
Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogsPamela L Tannenbaum, Joanne Stevens, Jacquelyn Binns, et al.
BMC Neuroscience|September 23, 2014
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulatorsAnthony L Gotter, Susan L Garson, Joanne Stevens, et al.
Journal of Neurogenetics|April 9, 2011
Promotion of sleep by suvorexant-a novel dual orexin receptor antagonistChristopher J Winrow, Anthony L Gotter, Christopher D Cox, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2014
Synthesis and evaluation of carbon-linked analogs of dual orexin receptor antagonist filorexantScott D Kuduk, Jason W Skudlarek, Christina N Di Marco, et al.
Journal of Neuroinflammation|September 19, 2021
The CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous systemSusana S Correia, Guang Liu, Sarah Jacobson, et al.
Neuropharmacology|October 25, 2011
Pharmacological characterization of MK-6096 - a dual orexin receptor antagonist for insomniaChristopher J Winrow, Anthony L Gotter, Christopher D Cox, et al.
Neuropharmacology|July 15, 2009
Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposureChristopher J Winrow, Keith Q Tanis, Duane R Reiss, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2010
Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the ratPaul J Coleman, John D Schreier, Anthony J Roecker, et al.
Frontiers in Neuroscience|January 9, 2014
Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulatorsAndres D Ramirez, Anthony L Gotter, Steven V Fox, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|November 8, 2016
Discovery of highly potent and selective orexin 1 receptor antagonists (1-SORAs) suitable for in vivo interrogation of orexin 1 receptor pharmacologyCraig A Stump, Andrew J Cooke, Joseph Bruno, et al.
Frontiers in Behavioral Neuroscience|June 7, 2014
Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogsPamela L Tannenbaum, Joanne Stevens, Jacquelyn Binns, et al.
BMC Neuroscience|September 23, 2014
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulatorsAnthony L Gotter, Susan L Garson, Joanne Stevens, et al.
Journal of Neurogenetics|April 9, 2011
Promotion of sleep by suvorexant-a novel dual orexin receptor antagonistChristopher J Winrow, Anthony L Gotter, Christopher D Cox, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2014
Synthesis and evaluation of carbon-linked analogs of dual orexin receptor antagonist filorexantScott D Kuduk, Jason W Skudlarek, Christina N Di Marco, et al.
Journal of Neuroinflammation|September 19, 2021
The CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous systemSusana S Correia, Guang Liu, Sarah Jacobson, et al.
Neuropharmacology|October 25, 2011
Pharmacological characterization of MK-6096 - a dual orexin receptor antagonist for insomniaChristopher J Winrow, Anthony L Gotter, Christopher D Cox, et al.
Neuropharmacology|July 15, 2009
Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposureChristopher J Winrow, Keith Q Tanis, Duane R Reiss, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2010
Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the ratPaul J Coleman, John D Schreier, Anthony J Roecker, et al.
Frontiers in Neuroscience|January 9, 2014
Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulatorsAndres D Ramirez, Anthony L Gotter, Steven V Fox, et al.
Pageof 6